t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with n-formylmethionine leucyl-phenylalanine in 15 studies
| Studies (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Trials (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Recent Studies (post-2010) (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 6,716 | 53 | 356 |
| Protein | Taxonomy | t-butyloxycarbonyl-methionyl-leucyl-phenylalanine (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, R; Edvinsson, L; Gullberg, U; Richter, J | 1 |
| Brunkhorst, BA; Budnick, M; Coppi, M; Kraus, E; Niederman, R | 1 |
| Bowles, CA; Linnekin, D; MacVittie, TJ; Murano, G | 1 |
| Lazzari, KG; Proto, P; Simons, ER | 1 |
| Columbo, M; Condorelli, M; Marone, G; Soppelsa, L | 1 |
| Jacob, J | 1 |
| Billah, MM; Egan, RW; Pai, JK; Siegel, MI | 1 |
| Fawcett, LB; Tripp, MR | 1 |
| Munekata, E; Takenouchi, T | 1 |
| Ciccarelli, A; Cirillo, R; de Crescenzo, G; de Paulis, A; Marone, G; Patella, V | 1 |
| Harford, F; Haydek, JM; Holmes, EW; Jacyno, M; Keshavarzian, A | 1 |
| Biondi, C; Corradini, FG; Ferretti, ME; Neri, LM; Pavan, B; Vesce, F | 1 |
| Wong, JT; Wong, YH; Yip, EC | 1 |
| Bylund, J; Dahlgren, C; Fu, H; Karlsson, J; Stenfeldt, AL; Wennerås, C | 1 |
| Bondar', OE; Mal'tseva, VN; Matveeva, NK; Safronova, VG; Sukhikh, GT; Van'ko, LV | 1 |
15 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Calcitonin gene-related peptide (CGRP) activates human neutrophils--inhibition by chemotactic peptide antagonist BOC-MLP.
Topics: Calcitonin Gene-Related Peptide; Calcium; Cells, Cultured; Humans; Lactoferrin; N-Formylmethionine Leucyl-Phenylalanine; Neurokinin A; Neutrophils; Oligopeptides; Pertussis Toxin; Substance P; Virulence Factors, Bordetella | 1992 |
Propionate induces polymorphonuclear leukocyte activation and inhibits formylmethionyl-leucyl-phenylalanine-stimulated activation.
Topics: Actins; Carboxylic Acids; Cell Movement; Cytoskeleton; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Microscopy, Fluorescence; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Pertussis Toxin; Propionates; Receptors, Formyl Peptide; Receptors, Immunologic; Time Factors; Virulence Factors, Bordetella | 1992 |
Migration of dog polymorphonuclear neutrophilic leukocytes to formylated peptides.
Topics: Animals; Chemotaxis, Leukocyte; Dogs; Drug Synergism; Escherichia coli; Female; GTP-Binding Proteins; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Receptors, Formyl Peptide; Receptors, Immunologic; Signal Transduction; Tetradecanoylphorbol Acetate | 1990 |
Neutrophil hyperpolarization in response to a chemotactic peptide.
Topics: Amino Acid Sequence; Calcium; Carbocyanines; Cell Membrane; Choline; Cytosol; Dose-Response Relationship, Drug; Fluorescent Dyes; Granulomatous Disease, Chronic; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Potassium; Potassium Channels; Sodium; Sodium-Potassium-Exchanging ATPase; Thiobarbiturates | 1990 |
Histamine release from human basophils by pepstatin A.
Topics: Basophils; Cytochalasin B; Deuterium; Dipeptides; Dose-Response Relationship, Drug; Histamine Release; Humans; Immunoglobulin E; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Pepstatins | 1985 |
Linear gramicidin activates neutrophil functions and the activation is blocked by chemotactic peptide receptor antagonist.
Topics: Animals; Chlortetracycline; Gramicidin; Kinetics; Lysosomes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Rabbits; Receptors, Formyl Peptide; Receptors, Immunologic; Spectrometry, Fluorescence; Superoxides | 1988 |
Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes.
Topics: Diglycerides; Enzyme Activation; Ethanol; Glycerophospholipids; Granulocytes; Humans; Kinetics; Leukemia, Myeloid; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Phosphates; Phosphatidic Acids; Phospholipase D; Phospholipases; Phospholipid Ethers; Platelet Activating Factor; Tumor Cells, Cultured | 1988 |
Chemotaxis of Mercenaria mercenaria hemocytes to bacteria in vitro.
Topics: Acetylglucosamine; Animals; Bivalvia; Chemotaxis; Escherichia coli; Hemocytes; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Staphylococcus aureus | 1994 |
beta-Amyloid peptide, substance P, and SEC receptor ligand activate cytoplasmic Ca2+ in neutrophil-like HL-60 cells: effect of chemotactic peptide antagonist BocMLF.
Topics: Amino Acid Sequence; Amyloid beta-Peptides; Calcium; Cell Line; Cytoplasm; Humans; Ligands; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Peptide Fragments; Receptors, Cell Surface; Substance P | 1995 |
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
Topics: Basophils; Binding, Competitive; Bryostatins; Chemokine CCL2; Chemokine CCL5; Complement C5a; Cyclosporine; Histamine Release; Humans; Interleukin-1; Interleukin-8; Kinetics; Lactones; Leukotriene C4; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Platelet Activating Factor; Protein Binding; Tetradecanoylphorbol Acetate | 1996 |
Modulatory effects of the colonic milieu on neutrophil oxidative burst: a possible pathogenic mechanism of ulcerative colitis.
Topics: Adult; Colectomy; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Female; Humans; Lipopolysaccharides; Luminescent Measurements; Luminol; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Reactive Oxygen Species; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate | 1997 |
Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca+]i rise.
Topics: Amnion; Binding Sites; Calcium; Cell Line; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Estrenes; Humans; Indomethacin; Microscopy, Confocal; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Pyrrolidinones; Quinacrine; Radioimmunoassay; Signal Transduction; Type C Phospholipases | 2001 |
Bacterial formyl peptide mediated chemotaxis and extracellular acidification in shrimp haemocytes.
Topics: Animals; Chemotaxis; Decapoda; Extracellular Space; Flow Cytometry; Fluorescent Dyes; Granulocytes; Hemocytes; Hydrogen-Ion Concentration; Microscopy, Fluorescence; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Proton-Translocating ATPases; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Rhodamines | 2001 |
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.
Topics: Complement C5a; Cyclosporine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oligopeptides; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Time Factors | 2007 |
Evaluation of the Role of FMLF chemotaxic peptide receptors in umbilical cord blood granulocytes from newborns at risk of infectious inflammatory diseases.
Topics: Case-Control Studies; Cells, Cultured; Communicable Diseases; Female; Fetal Blood; Granulocytes; Humans; Infant, Newborn; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Receptors, Formyl Peptide; Risk Factors; Systemic Inflammatory Response Syndrome | 2008 |